指南与共识中毒与环境急症呼吸衰竭与机械通气重症综合管理与镇静镇痛

突发群体性光气中毒的基础研究与临床创新治疗

[Basic research and clinical innovative treatment in patients with sudden mass phosgene poisoning].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2023-01-01
一句话结论光气中毒可致急性肺损伤并进展为急性呼吸窘迫综合征,死亡率高达40%-50%,本共识汇总病理生理机制、临床表现、现场处置与创新疗法以指导临床救援。

光气既是危险的窒息性化学战剂,也是广泛使用的化工原料;中国有1000余家光气生产企业,年产量超300万吨,从业人员数十万,生产、储存和运输中泄漏常致大批人员伤亡。近20年中国光气中毒事故时有发生,现场光气刺激性弱、密度高、浓度高,常致暴露者急性高浓度吸入,引发急性肺损伤,并很可能进展为急性呼吸窘迫综合征,死亡率高达40%-50%。鉴于光气中毒突发、群体、隐蔽、快速、高致死的特点及其毒理和致病机制尚不明确,目前缺乏有效治疗和规范化指导。本文结合多年光气基础研究与突发群体性光气中毒现场救治经验,汇总病理生理机制、临床表现、现场处置、研究进展和创新临床疗法,旨在为临床救援和治疗提供指导、提高救治水平。

要点

  • 中国有1000余家光气生产企业,年产量超300万吨,从业人员数十万,生产、储存、运输中泄漏常致大批人员伤亡。
  • 现场光气刺激性弱、密度高、浓度高,常致暴露者急性高浓度吸入,引发急性肺损伤,并很可能进展为急性呼吸窘迫综合征。
  • 光气中毒死亡率高达40%-50%。
  • 光气中毒具有突发、群体、隐蔽、快速、高致死的特点,其毒理和致病机制尚不明确,目前缺乏有效治疗和规范化指导。
  • 本共识结合多年基础研究与现场救治经验,汇总病理生理机制、临床表现、现场处置、研究进展和创新临床疗法,为临床救援提供指导。

适用人群与场景

  • 突发群体性光气中毒患者,因生产、储存、运输中泄漏事故导致大批人员暴露。

红旗征与不能漏的情况

  • 现场光气刺激性弱、密度高、浓度高,常致暴露者急性高浓度吸入,引发急性肺损伤,并很可能进展为急性呼吸窘迫综合征,死亡率高达40%-50%。

研究设计与关键结果

  • 本文为共识性文章,结合多年光气基础研究与突发群体性光气中毒现场救治经验,汇总了病理生理机制、临床表现、现场处置、研究进展和创新临床疗法。

对床旁实践的改变

  • 本共识旨在为突发群体性光气中毒患者的临床救援和治疗提供指导,以提高救治水平。

指南或共识出处

  • 本文为突发群体性光气中毒临床救援与治疗共识,具体名称和发布机构原文未明确。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「证据类型、等级与局限」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Phosgene is not only a dangerous asphyxiating chemical warfare agent, but also an important chemical raw material, which is widely used in chemical production. According to statistics, there are more than 1 000 phosgene production enterprises in China, with an annual production volume of more than 3 million tons and hundreds of thousands of employees. Therefore, once the leakage accident occurs during production, storage and transportation, it often causes a large number of casualties. In the past 20 years, phosgene poisoning accidents in China have occurred from time to time, and due to the weak irritation, high density, and high concentration of phosgene at the scene of the accident, it often results in acute high-concentration inhalation of the exposed, triggering acute lung injury (ALI), and is very likely to progress to acute respiratory distress syndrome (ARDS), with a mortality rate up to 40%-50%. In view of the characteristics of sudden, mass, concealed, rapid and highly fatal phosgene, and the mechanism of its toxicity and pathogenicity is still not clear, there is no effective treatment and standardized guidance for the sudden group phosgene poisoning. In order to improve the efficiency of clinical treatment and reduce the mortality, this paper has summarized the pathophysiological mechanism of phosgene poisoning, clinical manifestations, on-site treatment, research progress, and innovative clinical therapies by combining the extensive basic research on phosgene over the years with the abundant experience in the on-site treatment of sudden mass phosgene poisoning. This consensus aims to provide guidance for the clinical rescue and treatment of patients with sudden mass phosgene poisoning, and to improve the level of treatment.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Yue M, Shen J. [Basic research and clinical innovative treatment in patients with sudden mass phosgene poisoning]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 38149382. doi:10.3760/cma.j.cn121430-20230717-00528

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。